BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2020 2:50:54 PM | Browse: 1037 | Download: 1641
 |
Received |
|
2020-03-09 14:31 |
 |
Peer-Review Started |
|
2020-03-09 14:33 |
 |
First Decision by Editorial Office Director |
|
2020-03-31 23:29 |
 |
Return for Revision |
|
2020-03-31 23:29 |
 |
Revised |
|
2020-06-04 10:20 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-06-16 09:17 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-06-16 23:00 |
 |
Articles in Press |
|
2020-06-16 23:00 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2020-07-06 01:51 |
 |
Publish the Manuscript Online |
|
2020-07-07 14:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Catherine Watson, Craig William Tallentire, John K Ramage, Rajaventhan Srirajaskanthan, Oscar R Leeuwenkamp and Donna Fountain |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Donna Fountain, PhD, Research Scientist, PHMR Health Economics, Pricing and Reimbursement, PHMR Head Office, London NW1 8XY, United Kingdom. donnafountain@phmr.com |
| Key Words |
Gastroenteropancreatic neuroendocrine tumours; Health-related quality of life; Systematic literature review; Chemotherapy; Biological therapies; Peptide receptor radionuclide therapy |
| Core Tip |
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are slow-growing cancers that arise from diffuse endocrine cells in the gastrointestinal tract and pancreas. An increased emphasis has been placed on health-related quality of life assessment in clinical studies, using reliable and validated patient-reported outcome instruments. Long-term therapeutic options provide symptomatic relief for patients with GEP-NETs, and can slow down or stabilise disease progression, but are not curative. Thus, understanding the impact of the long-term treatment options is particularly important. The aim of this study was to perform a systematic review to assess health-related quality of life focusing on patients with inoperable metastatic GEP-NETs undergoing different treatments in order to uncover areas for future research. |
| Publish Date |
2020-07-07 14:50 |
| Citation |
Watson C, Tallentire CW, Ramage JK, Srirajaskanthan R, Leeuwenkamp OR, Fountain D. Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review. World J Gastroenterol 2020; 26(25): 3686-3711 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i25/3686.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i25.3686 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.